Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Perez-Medina

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Frontiers in Oncology|May 15, 2026
Drug-tolerant persister cells in cancer: a scoping review of definitions, models, and molecular mechanismsJose S Lopez-Gonzalez, Mario Perez-Medina, Miriam Galicia-Velasco, et al.
Frontiers in Oncology|October 29, 2020
The Double-Edge Sword of Autophagy in Cancer: From Tumor Suppression to Pro-tumor ActivityRodolfo Chavez-Dominguez, Mario Perez-Medina, Jose S Lopez-Gonzalez, et al.
Experimental Eye Research|October 24, 2025
Insights and advancements in molecular biology techniques in ophthalmologyNadia Flores-Huerta, Karla Tovar-Hernández, Mario Perez-Medina, et al.
Frontiers in Immunology|January 28, 2026
The tumor microenvironment: adding pieces to the puzzleDolores Aguilar-Cazares, Mario Perez-Medina, Jesus J Benito-Lopez, et al.
Frontiers in Oncology|January 30, 2023
Partners in crime: The feedback loop between metabolic reprogramming and immune checkpoints in the tumor microenvironmentJesus J Benito-Lopez, Mario Marroquin-Muciño, Mario Perez-Medina, et al.
Frontiers in Oncology|December 9, 2021
Old and New Players of Inflammation and Their Relationship With Cancer DevelopmentRodolfo Chavez-Dominguez, Mario Perez-Medina, Dolores Aguilar-Cazares, et al.
Frontiers in Endocrinology|September 8, 2022
The systemic-level repercussions of cancer-associated inflammation mediators produced in the tumor microenvironmentDolores Aguilar-Cazares, Rodolfo Chavez-Dominguez, Mario Marroquin-Muciño, et al.
International Journal of Molecular Sciences|November 27, 2024
SOCS1 Inhibits IL-6-Induced CD155 Overexpression in Lung AdenocarcinomaMario Marroquin-Muciño, Jesus J Benito-Lopez, Mario Perez-Medina, et al.
Frontiers in Oncology|November 2, 2023
Transcriptional signature of early cisplatin drug-tolerant persister cells in lung adenocarcinomaRodolfo Chavez-Dominguez, Dolores Aguilar-Cazares, Mario Perez-Medina, et al.
Cancers|July 13, 2024
Transcriptomic Analysis Reveals Early Alterations Associated with Intrinsic Resistance to Targeted Therapy in Lung Adenocarcinoma Cell LinesMario Perez-Medina, Jose S Lopez-Gonzalez, Jesus J Benito-Lopez, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Frontiers in Oncology|May 15, 2026
Drug-tolerant persister cells in cancer: a scoping review of definitions, models, and molecular mechanismsJose S Lopez-Gonzalez, Mario Perez-Medina, Miriam Galicia-Velasco, et al.
Frontiers in Oncology|October 29, 2020
The Double-Edge Sword of Autophagy in Cancer: From Tumor Suppression to Pro-tumor ActivityRodolfo Chavez-Dominguez, Mario Perez-Medina, Jose S Lopez-Gonzalez, et al.
Experimental Eye Research|October 24, 2025
Insights and advancements in molecular biology techniques in ophthalmologyNadia Flores-Huerta, Karla Tovar-Hernández, Mario Perez-Medina, et al.
Frontiers in Immunology|January 28, 2026
The tumor microenvironment: adding pieces to the puzzleDolores Aguilar-Cazares, Mario Perez-Medina, Jesus J Benito-Lopez, et al.
Frontiers in Oncology|January 30, 2023
Partners in crime: The feedback loop between metabolic reprogramming and immune checkpoints in the tumor microenvironmentJesus J Benito-Lopez, Mario Marroquin-Muciño, Mario Perez-Medina, et al.
Frontiers in Oncology|December 9, 2021
Old and New Players of Inflammation and Their Relationship With Cancer DevelopmentRodolfo Chavez-Dominguez, Mario Perez-Medina, Dolores Aguilar-Cazares, et al.
Frontiers in Endocrinology|September 8, 2022
The systemic-level repercussions of cancer-associated inflammation mediators produced in the tumor microenvironmentDolores Aguilar-Cazares, Rodolfo Chavez-Dominguez, Mario Marroquin-Muciño, et al.
International Journal of Molecular Sciences|November 27, 2024
SOCS1 Inhibits IL-6-Induced CD155 Overexpression in Lung AdenocarcinomaMario Marroquin-Muciño, Jesus J Benito-Lopez, Mario Perez-Medina, et al.
Frontiers in Oncology|November 2, 2023
Transcriptional signature of early cisplatin drug-tolerant persister cells in lung adenocarcinomaRodolfo Chavez-Dominguez, Dolores Aguilar-Cazares, Mario Perez-Medina, et al.
Cancers|July 13, 2024
Transcriptomic Analysis Reveals Early Alterations Associated with Intrinsic Resistance to Targeted Therapy in Lung Adenocarcinoma Cell LinesMario Perez-Medina, Jose S Lopez-Gonzalez, Jesus J Benito-Lopez, et al.
Pageof 2